ACCD:NSD-Accolade Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 7.89

Change

0.00 (0.00)%

Market Cap

USD 0.61B

Volume

1.49M

Analyst Target

USD 41.07
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

N/A

USD 37.50B
HQY HealthEquity Inc

N/A

USD 6.92B
RCM R1 RCM Inc

N/A

USD 5.04B
TXG 10X Genomics Inc

N/A

USD 3.29B
PGNY Progyny Inc

N/A

USD 3.05B
CERT Certara Inc

N/A

USD 2.83B
GDRX Goodrx Holdings Inc

N/A

USD 2.70B
PINC Premier Inc

N/A

USD 2.51B
PRVA Privia Health Group Inc

N/A

USD 2.15B
BTSG BrightSpring Health Services I..

N/A

USD 1.81B

ETFs Containing ACCD

ARKG 0.00 % 0.75 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -34.30% 24% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -34.30% 24% F 16% F
Trailing 12 Months  
Capital Gain -41.69% 51% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -41.69% 51% F 22% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -18.05% 37% F 20% F
Dividend Return -18.05% 37% F 19% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 44.52% 38% F 38% F
Risk Adjusted Return -40.55% 42% F 23% F
Market Capitalization 0.61B 69% C- 67% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative earnings

The company had negative total earnings in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.